These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1519333)

  • 1. White cell reduction, ultraviolet irradiation, and platelet refractoriness in acute myeloid leukemia.
    Blumberg N; Heal JM
    Transfusion; 1992 Sep; 32(7):688-9. PubMed ID: 1519333
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness.
    Carr R; Hutton JL; Jenkins JA; Lucas GF; Amphlett NW
    Br J Haematol; 1990 Jul; 75(3):408-13. PubMed ID: 2201403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory response to platelet transfusion therapy.
    Eisenberg S
    J Infus Nurs; 2010; 33(2):89-97. PubMed ID: 20228646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perils of platelet transfusions.
    Kruskall MS
    N Engl J Med; 1997 Dec; 337(26):1914-5. PubMed ID: 9407160
    [No Abstract]   [Full Text] [Related]  

  • 6. Change of ABO blood type in a patient with leukemia.
    HOOGSTRATEN B; ROSENFIELD RE; WASSERMAN LR
    Transfusion; 1961; 1():32-5. PubMed ID: 13715714
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfusion of apheresis platelets and ABO groups.
    Vox Sang; 2005 Apr; 88(3):207-21. PubMed ID: 15787735
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukocyte-depleted blood components prevent platelet refractoriness in patients with acute myeloid leukemia.
    Oksanen K
    Eur J Haematol; 1994 Aug; 53(2):100-7. PubMed ID: 8088380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired B antigen detectable only with LISS.
    Lord G; Elamin EM
    Med Lab Sci; 1982 Apr; 39(2):199-200. PubMed ID: 6956786
    [No Abstract]   [Full Text] [Related]  

  • 10. Energetics of DNA repair in UV-irradiated peripheral blood leukocytes from chronic myeloid leukaemia patients.
    Verma A; Sharma R; Jain VK
    Photochem Photobiol; 1982 Dec; 36(6):627-32. PubMed ID: 6961469
    [No Abstract]   [Full Text] [Related]  

  • 11. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
    Sintnicolaas K; Löwenberg B
    Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energetics of DNA repair: effects of temperature on DNA repair in UV-irradiated peripheral blood leucocytes from chronic myeloid leukemic patients.
    Sharma A; Sharma R; Jain VK
    Photochem Photobiol; 1988 May; 47(5):731-6. PubMed ID: 3165532
    [No Abstract]   [Full Text] [Related]  

  • 13. ABO incompatible platelets: risks versus benefit.
    Dunbar NM; Ornstein DL; Dumont LJ
    Curr Opin Hematol; 2012 Nov; 19(6):475-9. PubMed ID: 22914587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia.
    Mielcarek M; Torok-Storb B; Storb R
    Bone Marrow Transplant; 2002 Oct; 30(8):547-8; author reply 548. PubMed ID: 12379898
    [No Abstract]   [Full Text] [Related]  

  • 15. Change in blood group phenotype.
    Balachandran V; Nair PM; Prasad K
    J Indian Med Assoc; 1996 Apr; 94(4):151, 153. PubMed ID: 8854634
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of ABO mismatching on a radioimmunoassay for platelet compatibility. Successful adsorption of ABO alloantibodies with synthetic A and B substance.
    Ellinger PJ; Morgan LK; Malecek AC; Chaplin H
    Transfusion; 1989 Feb; 29(2):134-8. PubMed ID: 2645695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombocyte functions in malignant blood diseases].
    Lisichkov T; Avramova D; Dobreva A; Meshkov T; Ignatova E
    Vutr Boles; 1987; 26(4):74-7. PubMed ID: 3478895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
    Lee EJ; Schiffer CA
    Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic transfusion reaction due to anti-A.
    Lundberg WB; McGinniss MH
    Transfusion; 1975; 15(1):1-9. PubMed ID: 1054197
    [No Abstract]   [Full Text] [Related]  

  • 20. [ABO blood groups and platelet transfusion].
    Eckstein R; Zeiler T; Zingsem J; Heuft HG; Musch R; Weisbach V
    Beitr Infusionsther; 1990; 26():157-9. PubMed ID: 1703819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.